Design, synthesis, and antitumor activity of stapled peptide inhibitors targeting the RAS-RAF interactions.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Design, synthesis, and antitumor activity of stapled peptide inhibitors targeting the RAS-RAF interactions.
- Published In:
- European journal of medicinal chemistry, 290, 117568 (2025)
- Authors:
- Han, Dan, Yu, Zhou, Zhang, Kai, Gai, Conghao, Zhang, Peichao, Chai, Xiaoyun, Zhuo, Xiaobing, Zhao, Qingjie, Zou, Yan, Zhu, Lie
- Database ID:
- RPEP-11264
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-11264APA
Han, Dan; Yu, Zhou; Zhang, Kai; Gai, Conghao; Zhang, Peichao; Chai, Xiaoyun; Zhuo, Xiaobing; Zhao, Qingjie; Zou, Yan; Zhu, Lie. (2025). Design, synthesis, and antitumor activity of stapled peptide inhibitors targeting the RAS-RAF interactions.. European journal of medicinal chemistry, 290, 117568. https://doi.org/10.1016/j.ejmech.2025.117568
MLA
Han, Dan, et al. "Design, synthesis, and antitumor activity of stapled peptide inhibitors targeting the RAS-RAF interactions.." European journal of medicinal chemistry, 2025. https://doi.org/10.1016/j.ejmech.2025.117568
RethinkPeptides
RethinkPeptides Research Database. "Design, synthesis, and antitumor activity of stapled peptide..." RPEP-11264. Retrieved from https://rethinkpeptides.com/research/han-2025-design-synthesis-and-antitumor
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.